ZHYB.F Stock Overview
Engages in the development and marketing of nervonic acid-based health supplements in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Zhong Yuan Bio-Technology Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$4.99 |
| 52 Week High | US$6.50 |
| 52 Week Low | US$1.47 |
| Beta | 3.76 |
| 11 Month Change | 0% |
| 3 Month Change | 3.53% |
| 1 Year Change | n/a |
| 33 Year Change | 24.75% |
| 5 Year Change | n/a |
| Change since IPO | 878.43% |
Recent News & Updates
Recent updates
Shareholder Returns
| ZHYB.F | US Personal Products | US Market | |
|---|---|---|---|
| 7D | 0% | -0.6% | 5.1% |
| 1Y | n/a | -9.9% | 37.7% |
Return vs Industry: Insufficient data to determine how ZHYB.F performed against the US Personal Products industry.
Return vs Market: Insufficient data to determine how ZHYB.F performed against the US Market.
Price Volatility
| ZHYB.F volatility | |
|---|---|
| ZHYB.F Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 8.0% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.1% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: ZHYB.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ZHYB.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | 35 | Tina Chang | www.zybioholdings.com |
Zhong Yuan Bio-Technology Holdings Limited engages in the development and marketing of nervonic acid-based health supplements in China. The company’s products include Neuro Enhancer nervonic acid oils, Muzhiyuan acer truncatum formula oils, Life’s NA candies, and seedlings of Acer Truncatum. In addition, it offers demyelination diagnostic kit and nervonic acid supplement.
Zhong Yuan Bio-Technology Holdings Limited Fundamentals Summary
| ZHYB.F fundamental statistics | |
|---|---|
| Market cap | US$88.32m |
| Earnings (TTM) | -US$303.46k |
| Revenue (TTM) | US$2.49m |
35.4x
P/S Ratio-291.0x
P/E RatioIs ZHYB.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZHYB.F income statement (TTM) | |
|---|---|
| Revenue | US$2.49m |
| Cost of Revenue | US$353.22k |
| Gross Profit | US$2.14m |
| Other Expenses | US$2.44m |
| Earnings | -US$303.46k |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.017 |
| Gross Margin | 85.84% |
| Net Profit Margin | -12.17% |
| Debt/Equity Ratio | 610.6% |
How did ZHYB.F perform over the long term?
See historical performance and comparison